Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Long-Term Deferred Tax (2023 - 2024)

Xtant Medical Holdings (XTNT) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $42000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Long-Term Deferred Tax rose 100.0% to $42000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $42000.0, a 100.0% increase, with the full-year FY2024 number at $42000.0, up 100.0% from a year prior.
  • Long-Term Deferred Tax was $42000.0 for Q4 2024 at Xtant Medical Holdings, up from $21000.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $42000.0 in Q4 2024 to a low of $21000.0 in Q4 2023.